Carfilzomib Thalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma

NCT03140943 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Relapsed and/or Refractory Multiple Myeloma

Interventions

DRUG: Carfilzomib, Thalidomide and Dexamethasone

Sponsor

National University Hospital, Singapore

Collaborators

[object Object]
[object Object]
[object Object]